Variant report

Variant	esv3395649
Chromosome Location	chr2:233739733-233742581
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:383)
CpG islands
(count:306)
Chromatin interactive
region (count:9)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:383 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr2:233740653-233741530	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL3	chr2:233742468-233742811	A549	lung:	n/a	n/a
3	BHLHE40	chr2:233740999-233741355	GM12878	blood:	n/a	n/a
4	BHLHE40	chr2:233740965-233741711	HepG2	liver:	n/a	n/a
5	CEBPB	chr2:233740541-233740634	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr2:233740570-233740611	HepG2	liver:	n/a	n/a
7	CEBPD	chr2:233740315-233740838	HepG2	liver:	n/a	n/a
8	CEBPD	chr2:233741739-233742135	HepG2	liver:	n/a	n/a
9	CEBPD	chr2:233741109-233741455	HepG2	liver:	n/a	n/a
10	CHD2	chr2:233741023-233741219	Hela-S3	cervix:	n/a	n/a
11	CHD2	chr2:233740646-233740754	Hela-S3	cervix:	n/a	n/a
12	CHD2	chr2:233741125-233741156	GM12878	blood:	n/a	n/a
13	CHD2	chr2:233740990-233741484	HepG2	liver:	n/a	n/a
14	CREB1	chr2:233741436-233741910	A549	lung:	n/a	n/a
15	CREB1	chr2:233740928-233741431	A549	lung:	n/a	n/a
16	CTCF	chr2:233740925-233741140	GM10248	blood:	n/a	n/a
17	CTCF	chr2:233740915-233741040	SK-N-SH_RA	brain:	n/a	n/a
18	CTCF	chr2:233740400-233740550	HRPEpiC	eye:	n/a	n/a
19	CTCF	chr2:233740920-233741070	AG04449	skin:	n/a	n/a
20	CTCF	chr2:233740940-233741090	HMEC	breast:	n/a	n/a
21	CTCF	chr2:233740914-233741085	MCF-7	breast:	n/a	n/a
22	CTCF	chr2:233740420-233740570	WERI-Rb-1	eye:	n/a	n/a
23	CTCF	chr2:233740917-233741111	GM12892	blood:	n/a	n/a
24	CTCF	chr2:233740920-233741070	GM12870	blood:	n/a	n/a
25	CTCF	chr2:233740941-233741149	GM12878	blood:	n/a	n/a
26	CTCF	chr2:233740440-233740590	HA-sp	spinal cord:	n/a	n/a
27	CTCF	chr2:233740980-233741130	Hela-S3	cervix:	n/a	n/a
28	CTCF	chr2:233741282-233741377	MCF-7	breast:	n/a	n/a
29	CTCF	chr2:233740440-233740590	SAEC	small airway:	n/a	n/a
30	CTCF	chr2:233740900-233741050	HEEpiC	esophagus:	n/a	n/a
31	CTCF	chr2:233740920-233741070	BJ	skin:	n/a	n/a
32	CTCF	chr2:233740360-233740510	HMEC	breast:	n/a	n/a
33	CTCF	chr2:233740920-233741070	GM12871	blood:	n/a	n/a
34	CTCF	chr2:233740371-233740584	MCF-7	breast:	n/a	n/a
35	CTCF	chr2:233740921-233741096	A549	lung:	n/a	n/a
36	CTCF	chr2:233740921-233741126	MCF-7	breast:	n/a	n/a
37	CTCF	chr2:233740360-233740510	GM12875	blood:	n/a	n/a
38	CTCF	chr2:233740413-233740535	A549	lung:	n/a	n/a
39	CTCF	chr2:233740360-233740510	AG04449	skin:	n/a	n/a
40	CTCF	chr2:233740900-233741050	GM12865	blood:	n/a	n/a
41	CTCF	chr2:233740400-233740550	RPTEC	kidney:	n/a	n/a
42	CTCF	chr2:233740410-233740549	HUVEC	blood vessel:	n/a	n/a
43	CTCF	chr2:233740920-233741070	GM12866	blood:	n/a	n/a
44	CTCF	chr2:233740928-233741106	Pancreas_OC	pancreas:	n/a	n/a
45	CTCF	chr2:233740400-233740543	MCF-7	breast:	n/a	n/a
46	CTCF	chr2:233740920-233741070	HPAF	blood vessel:	n/a	n/a
47	CTCF	chr2:233740898-233741118	NHEK	skin:	n/a	n/a
48	CTCF	chr2:233741000-233741150	NHEK	skin:	n/a	n/a
49	CTCF	chr2:233741095-233741097	GM19239	blood:	n/a	n/a
50	CTCF	chr2:233740394-233740563	GM19240	blood:	n/a	n/a

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:233741920-233741970	AG09309	skin:	n/a
2	chr2:233741920-233741970	AG09309	skin:	n/a
3	chr2:233741920-233741970	HUVEC	blood vessel:	n/a
4	chr2:233740669-233740719	ECC-1	luminal epithelium:	n/a
5	chr2:233740669-233740719	HCM	heart:	n/a
6	chr2:233741084-233741134	CMK	blood:	n/a
7	chr2:233741084-233741134	HIPEpiC	eye:	n/a
8	chr2:233741920-233741970	HCM	heart:	n/a
9	chr2:233741084-233741134	ProgFib	skin:	n/a
10	chr2:233741920-233741970	CMK	blood:	n/a
11	chr2:233740669-233740719	GM12892	blood:	n/a
12	chr2:233741790-233741840	HL-60	blood:	n/a
13	chr2:233741639-233741689	PFSK-1	brain:	n/a
14	chr2:233740669-233740719	HUVEC	blood vessel:	n/a
15	chr2:233741084-233741134	AG04449	skin:	fetal
16	chr2:233741639-233741689	HMEC	breast:	n/a
17	chr2:233740669-233740719	HRPEpiC	eye:	n/a
18	chr2:233741084-233741134	HL-60	blood:	n/a
19	chr2:233741920-233741970	GM12892	blood:	n/a
20	chr2:233740669-233740719	HPAEpiC	pulmonary alveolar:	n/a
21	chr2:233741639-233741689	PrEC	prostate:	n/a
22	chr2:233740669-233740719	LNCaP	prostate:	n/a
23	chr2:233741790-233741840	HCM	heart:	n/a
24	chr2:233741790-233741840	HAEpiC	amniotic membrane:	n/a
25	chr2:233741790-233741840	HMEC	breast:	n/a
26	chr2:233740669-233740719	H1-hESC	embryonic stem cell:	embryo
27	chr2:233741084-233741134	GM06990	blood:	n/a
28	chr2:233741790-233741840	AG09309	skin:	n/a
29	chr2:233740669-233740719	PrEC	prostate:	n/a
30	chr2:233741084-233741134	HEEpiC	esophagus:	n/a
31	chr2:233741639-233741689	SK-N-SH_RA	brain:	n/a
32	chr2:233741084-233741134	U87	brain:	n/a
33	chr2:233741920-233741970	HNPCEpiC	eye:	n/a
34	chr2:233741639-233741689	GM19239	blood:	n/a
35	chr2:233741920-233741970	SAEC	small airway:	n/a
36	chr2:233741790-233741840	Hela-S3	cervix:	n/a
37	chr2:233741920-233741970	LNCaP	prostate:	n/a
38	chr2:233741790-233741840	A549	lung:	n/a
39	chr2:233741639-233741689	HIPEpiC	eye:	n/a
40	chr2:233741920-233741970	NHBE	bronchial:	n/a
41	chr2:233740669-233740719	ProgFib	skin:	n/a
42	chr2:233741790-233741840	PANC-1	pancreas:	n/a
43	chr2:233741790-233741840	NHBE	bronchial:	n/a
44	chr2:233741639-233741689	GM12891	blood:	n/a
45	chr2:233741084-233741134	MCF-7	breast:	n/a
46	chr2:233741920-233741970	HepG2	liver:	n/a
47	chr2:233741084-233741134	GM12878	blood:	n/a
48	chr2:233741084-233741134	HPAEpiC	pulmonary alveolar:	n/a
49	chr2:233740669-233740719	RPTEC	kidney:	n/a
50	chr2:233741639-233741689	HL-60	blood:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:233739634..233741752-chr2:234762062..234763820,2	MCF-7	breast:
2	chr2:233733606..233736578-chr2:233738541..233742093,3	K562	blood:
3	chr2:233741247..233743514-chr2:233891035..233893052,2	MCF-7	breast:
4	chr2:233739669..233741368-chr2:233754744..233756796,2	MCF-7	breast:
5	chr2:233738643..233740986-chr2:234158854..234161597,2	MCF-7	breast:
6	chr2:233741423..233744026-chr2:234158649..234161710,3	MCF-7	breast:
7	chr2:233739500..233741658-chr2:234118418..234121019,2	MCF-7	breast:
8	chr2:233739591..233745527-chr2:233747956..233752237,8	MCF-7	breast:
9	chr2:233733606..233736774-chr2:233738541..233741120,3	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GIGYF2-2	chr2:233741231-233741633	NONHSAT077456

No data

Variant related genes	Relation type
C2orf82	TF binding region
C2orf82	CpG island
ENSG00000066248	chromatin interactions
ENSG00000182600	chromatin interactions
ENSG00000123485	chromatin interactions
ENSG00000085978	chromatin interactions

Extended variants
information (count: 102 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:102 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557432570	chr2:233739741-233739742	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs567649061	chr2:233739776-233739777	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs7602208	chr2:233739798-233739799	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
4	rs553415115	chr2:233739799-233739800	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs369828192	chr2:233739809-233739810	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs138106910	chr2:233739815-233739816	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs558675921	chr2:233739866-233739867	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs575539727	chr2:233739877-233739878	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs113504070	chr2:233739942-233739943	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs563182156	chr2:233739963-233739964	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs144011660	chr2:233739985-233739986	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs530176523	chr2:233740043-233740044	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs35523521	chr2:233740056-233740057	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs67272467	chr2:233740067-233740068	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs13024812	chr2:233740070-233740071	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs542227014	chr2:233740087-233740088	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs368852361	chr2:233740103-233740104	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs559424105	chr2:233740129-233740130	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs528148254	chr2:233740142-233740143	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs181588071	chr2:233740146-233740147	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs534172721	chr2:233740151-233740152	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs75834091	chr2:233740177-233740178	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs77242521	chr2:233740202-233740203	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs569791055	chr2:233740203-233740204	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs371922364	chr2:233740215-233740216	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs778338	chr2:233740227-233740228	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
27	rs567586121	chr2:233740234-233740235	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs113321658	chr2:233740284-233740285	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs558395878	chr2:233740285-233740286	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs571794473	chr2:233740299-233740300	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs778337	chr2:233740391-233740392	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs373201550	chr2:233740409-233740410	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs35619877	chr2:233740420-233740421	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs527376817	chr2:233740495-233740496	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs186247973	chr2:233740568-233740569	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs539023495	chr2:233740576-233740577	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs11548558	chr2:233740611-233740612	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs558764717	chr2:233740625-233740626	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs576334908	chr2:233740636-233740637	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs377340430	chr2:233740670-233740671	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs201237663	chr2:233740732-233740733	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs538183598	chr2:233740780-233740781	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs555262523	chr2:233740816-233740817	Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs200671292	chr2:233740822-233740823	Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs111250815	chr2:233740832-233740833	Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs542613686	chr2:233740887-233740888	Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs559047099	chr2:233740895-233740896	Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs573016744	chr2:233740923-233740924	Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs545122636	chr2:233740936-233740937	Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs565105797	chr2:233740942-233740943	Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:429 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:233723000-233740400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr2:233726000-233740400	Weak transcription	HMEC	breast
3	chr2:233726400-233740200	Weak transcription	Primary B cells from cord blood	blood
4	chr2:233726400-233740400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
5	chr2:233726400-233740800	Weak transcription	HSMM	muscle
6	chr2:233726600-233739800	Weak transcription	Muscle Satellite Cultured Cells	--
7	chr2:233726600-233740000	Weak transcription	Pancreas	Pancrea
8	chr2:233726600-233740200	Weak transcription	Rectal Smooth Muscle	rectum
9	chr2:233726600-233740400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
10	chr2:233726600-233740400	Weak transcription	Lung	lung
11	chr2:233726600-233740400	Weak transcription	NHEK	skin
12	chr2:233726800-233755600	Weak transcription	HSMMtube	muscle
13	chr2:233734400-233740400	Enhancers	Brain Inferior Temporal Lobe	brain
14	chr2:233734600-233740200	Enhancers	Brain Cingulate Gyrus	brain
15	chr2:233734600-233740200	Enhancers	Brain Substantia Nigra	brain
16	chr2:233734800-233740200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
17	chr2:233735000-233740000	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
18	chr2:233735000-233740000	Genic enhancers	Fetal Intestine Small	intestine
19	chr2:233736400-233740200	Enhancers	Fetal Intestine Large	intestine
20	chr2:233736600-233740200	Enhancers	Brain Hippocampus Middle	brain
21	chr2:233736800-233740200	Weak transcription	Fetal Brain Male	brain
22	chr2:233738000-233740000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr2:233738000-233740000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr2:233738000-233740200	Enhancers	Colonic Mucosa	Colon
25	chr2:233738200-233740400	Enhancers	Liver	Liver
26	chr2:233738600-233740000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
27	chr2:233738600-233740200	Enhancers	A549	lung
28	chr2:233738600-233740600	Enhancers	Spleen	Spleen
29	chr2:233738800-233740200	Enhancers	Hela-S3	cervix
30	chr2:233738800-233741000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr2:233739000-233740000	Weak transcription	Brain Anterior Caudate	brain
32	chr2:233739200-233740200	Weak transcription	Brain Angular Gyrus	brain
33	chr2:233739400-233739800	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
34	chr2:233739400-233739800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
35	chr2:233739400-233740000	Enhancers	Rectal Mucosa Donor 29	rectum
36	chr2:233739400-233740200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
37	chr2:233739400-233740400	Weak transcription	Esophagus	oesophagus
38	chr2:233739400-233740600	Enhancers	Gastric	stomach
39	chr2:233739400-233740600	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
40	chr2:233739400-233740600	Bivalent Enhancer	Stomach Mucosa	stomach
41	chr2:233739600-233740000	Flanking Active TSS	Duodenum Mucosa	Duodenum
42	chr2:233739600-233740000	Enhancers	Rectal Mucosa Donor 31	rectum
43	chr2:233739600-233740000	Enhancers	HepG2	liver
44	chr2:233739800-233740600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
45	chr2:233740000-233740200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
46	chr2:233740000-233740200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr2:233740000-233740200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr2:233740000-233740200	Enhancers	Brain Anterior Caudate	brain
49	chr2:233740000-233740200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
50	chr2:233740000-233740400	Enhancers	Breast Myoepithelial Primary Cells	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links